Search Results 1631-1640 of 16883 for monoclonal antibody

1. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

   Subjects with a positive test for Hepatitis C (HCV) antibody are excluded, regardless of viral load. If hepatitis C antibody is positive, confirmatory tests may ...

2. A Study to Evaluate the Safety, PK/​PD of (OriCAR-017) in Subjects With RR/​MM - RIGEL Study - Mayo Clinic

   ... antibody (e.g., teclistamab), BCMA antibody directed conjugate (such as BLENREP), and BCMA-CAR-T (such as CARVYKT1TM); Subjects with adequate hematologic ...

3. A Study to Evaluate Kidney Care and HistoMap in Microvascular Inflammation - Mayo Clinic

   ... Antibodies (DSA) as compared to cohort with normal biopsies without DSA. ... Previous history cell mediated or antibody mediated rejection or mixed rejection.

4. Neurology - Doctors - Mayo Clinic

   yte glycoprotein antibody-associated disease, Paraneoplastic syndromes of the nervous system, Demyelinating disease, Neurosarcoidosis. Show more areas of ...

5. A Study to Investigate the Safety and Tolerability of REGN1979 in Patients With CD20+ B-Cell Malignancies - Mayo Clinic

   ... antibody may be appropriate: B-NHL confirmed by NCI working group criteria, 2007 (Cheson 2007) (Appendix 2);; CLL confirmed by the International Workshop on ...

6. Overview - T Cell Engineering Laboratory - Mayo Clinic Research

   CAR-T cell therapy is a novel immunotherapeutic approach to treat cancer. A chimeric antigen receptor is a synthetic antibody on the surface of T cells that ...

7. A Study to Evaluate the Safety and Effectiveness of BIIB054 in Subjects with Parkinson’s Disease - Mayo Clinic

   ... antibody (HCVAb). Current hepatitis B infection (defined as positive for hepatitis B surface antigen [HBsAg] and/or total hepatitis B core antibody [anti-HBc]).

8. A Study to Evaluate Tadalafil and Lenalidomide with or without Activated Marrow Infiltrating Lymphocytes (MILs) in High Risk Myeloma - Mayo Clinic

   POEMS syndrome (plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, monoclonal protein [M-protein] and skin changes);; Non-secretory ...

9. A Study to Evaluate Adjuvant Ado-Trastuzumab Emtansine (T-DM1) in HER2 Positive Breast Cancer - Mayo Clinic

   Positive Hepatitis B (Hepatitis B surface antigen and antibody) and/or Hepatitis C (Hepatitis C antibody test) as indicated by serologies conducted ≤3 ...

10. Clinical trials - Oncology (Medical)

    This is a Phase I/II study designed to evaluate if experimental anti-TIGIT/anti-PD-1 bispecific antibody rilvegostomig (AZD2936) is safe, tolerable and ...